Shire’s ADHD amphetamine wins British backing

LONDON (Reuters) – Shire’s hyperactivity treatment Vyvanse will be available in Europe within months after Britain’s drugs regulator backed the amphetamine-based stimulant used to treat millions of U.S. students. The drug, lisdexamfetamine dimesylate, has a slow-release action that activates the amphetamine ingredient over the course of a day, helping levels of alertness and concentration in children with ADHD (attention deficit hyperactivity disorder). It was assessed under the European Union’s decentralized approvals procedure, led by Britain’s medicines watchdog. …

Medication cuts crime rate among ADHD sufferers

LONDON (Reuters) – Criminal behavior in adults with attention deficit hyperactivity disorder (ADHD) drops sharply when they take stimulant drugs like Ritalin to help them to control impulses, scientists said on Wednesday. A study of more than 25,000 people with ADHD found the number of crimes committed was about a third or more lower in those taking medication, suggesting that encouraging ADHD patients to stay on the pills could cut the risk of crime. …

1 2 3